This compound is primarily utilized in pharmaceutical research and development as a key intermediate in the synthesis of complex organic molecules. Its structure, featuring both a spirocyclic system and a bromo substituent, makes it valuable for constructing biologically active compounds, particularly in the development of central nervous system (CNS) drugs. The tert-butyl carboxylate group enhances its stability and reactivity, facilitating further chemical modifications. Researchers often employ it in the preparation of potential therapeutic agents targeting neurological disorders, such as anxiety, depression, or schizophrenia. Its versatility also extends to medicinal chemistry, where it serves as a building block for designing novel drug candidates with improved efficacy and selectivity.